AstraZeneca PLC
Status: Publicly traded
Direct answer
AstraZeneca PLC is publicly traded on LSE under the ticker AZN.L.
AstraZeneca PLC operates as a biopharmaceutical company, specializing in the discovery, development, manufacturing, and commercialization of prescription medications. Its comprehensive portfolio addresses diverse therapeutic areas. In oncology, key marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. For cardiovascular, renal, and...
Can you invest in AstraZeneca PLC?
Yes. AstraZeneca PLC trades publicly on LSE as AZN.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AstraZeneca PLC
Detailed equity research is provided by MarketSnap.